Brain Cancer Clinical Trials in Tennessee

Showing 41-60 of 92 trials

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

NCT02386826

The purpose of this study is to determine whether the combination of two agents, INC280 and bevacizumab, is safe and effective when administered to patients with Glioblastoma Multiforme (GBM) who have progressed after receiving prior therapy or who have unresectable GBM.

Glioblastoma MultiformeGliosarcomaColorectal Cancer+1 more

SCRI Development Innovations, LLC65 participantsStarted Sep 2015

Denver, Colorado, United States • New Haven, Connecticut, United States • Kansas City, Missouri, United States +2 more locations

AVAILABLE29 miles

Expanded Access Protocol Using 131I-MIBG

NCT01590680

Protocol JDI2007-01 is an Expanded Access Protocol with therapeutic 131I-MIBG for patients with neuroblastoma or pheochromocytoma / paraganglioma, who otherwise do not qualify for available treatments, or where approved treatment is not commercially available.

NeuroblastomaPheochromocytomaParaganglioma

Jubilant DraxImage Inc.

Los Angeles, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +16 more locations

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Expanded Access Protocol Using 131I-MIBG

Brain Cancer Trials in Other Cities

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

Illness Management and Parental Adjustment to Cancer Treatment

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

UNITE Study: Understanding New Interventions With GBM ThErapy

Gliogene: Brain Tumor Linkage Study

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Other Conditions in Tennessee